25 XP   0   0   10

Organovo Holdings Inc
Buy, Hold or Sell?

Let's analyse Organovo together

PenkeI guess you are interested in Organovo Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Organovo Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Organovo Holdings Inc

I send you an email if I find something interesting about Organovo Holdings Inc.

Quick analysis of Organovo (30 sec.)










What can you expect buying and holding a share of Organovo? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.62
Expected worth in 1 year
$-0.99
How sure are you?
17.5%

+ What do you gain per year?

Total Gains per Share
$-1.60
Return On Investment
-158.8%

For what price can you sell your share?

Current Price per Share
$1.01
Expected price per share
$0.8911 - $1.27
How sure are you?
50%

1. Valuation of Organovo (5 min.)




Live pricePrice per Share (EOD)

$1.01

Intrinsic Value Per Share

$-23.06 - $-9.55

Total Value Per Share

$-22.44 - $-8.94

2. Growth of Organovo (5 min.)




Is Organovo growing?

Current yearPrevious yearGrowGrow %
How rich?$6.1m$26.2m-$14.9m-132.2%

How much money is Organovo making?

Current yearPrevious yearGrowGrow %
Making money-$5.5m-$2.8m-$2.6m-47.8%
Net Profit Margin-20,250.7%-1,681.4%--

How much money comes from the company's main activities?

3. Financial Health of Organovo (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Organovo? (5 min.)

Welcome investor! Organovo's management wants to use your money to grow the business. In return you get a share of Organovo.

What can you expect buying and holding a share of Organovo?

First you should know what it really means to hold a share of Organovo. And how you can make/lose money.

Speculation

The Price per Share of Organovo is $1.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Organovo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Organovo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.62. Based on the TTM, the Book Value Change Per Share is $-0.40 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Organovo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.36-35.5%-0.39-38.6%-0.29-28.9%-0.40-39.2%-0.72-71.3%
Usd Book Value Change Per Share-0.23-22.4%-0.40-39.7%-0.22-22.2%-0.15-14.5%-0.11-10.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-22.4%-0.40-39.7%-0.22-22.2%-0.15-14.5%-0.11-10.5%
Usd Price Per Share1.11-1.56-2.25-3.40-3.43-
Price to Earnings Ratio-0.77--0.99--2.24--2.77--1.85-
Price-to-Total Gains Ratio-4.90--3.30--13.69--1.24--5.16-
Price to Book Ratio1.80-1.46-0.84-1.41-1.04-
Price-to-Total Gains Ratio-4.90--3.30--13.69--1.24--5.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.01
Number of shares990
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.40-0.15
Usd Total Gains Per Share-0.40-0.15
Gains per Quarter (990 shares)-397.06-145.41
Gains per Year (990 shares)-1,588.22-581.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1588-15980-582-592
20-3176-31860-1163-1174
30-4765-47740-1745-1756
40-6353-63620-2327-2338
50-7941-79500-2908-2920
60-9529-95380-3490-3502
70-11118-111260-4071-4084
80-12706-127140-4653-4666
90-14294-143020-5235-5248
100-15882-158900-5816-5830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%1.051.00.01.9%
Book Value Change Per Share0.03.01.00.0%1.010.01.08.3%3.016.01.015.0%7.032.01.017.5%12.038.02.023.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.052.00.0%
Total Gains per Share0.03.01.00.0%1.010.01.08.3%3.016.01.015.0%7.032.01.017.5%12.038.02.023.1%

Fundamentals of Organovo

About Organovo Holdings Inc

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-03-21 02:17:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Organovo Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Organovo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Organovo to the Biotechnology industry mean.
  • A Net Profit Margin of -72,080.0% means that $-720.80 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Organovo Holdings Inc:

  • The MRQ is -72,080.0%. The company is making a huge loss. -2
  • The TTM is -20,250.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-72,080.0%TTM-20,250.7%-51,829.3%
TTM-20,250.7%YOY-1,681.4%-18,569.3%
TTM-20,250.7%5Y-4,475,004,567.2%+4,474,984,316.5%
5Y-4,475,004,567.2%10Y-2,237,503,731.4%-2,237,500,835.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-72,080.0%-171.8%-71,908.2%
TTM-20,250.7%-205.8%-20,044.9%
YOY-1,681.4%-262.1%-1,419.3%
5Y-4,475,004,567.2%-455.6%-4,475,004,111.6%
10Y-2,237,503,731.4%-589.0%-2,237,503,142.4%
1.1.2. Return on Assets

Shows how efficient Organovo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Organovo to the Biotechnology industry mean.
  • -40.6% Return on Assets means that Organovo generated $-0.41 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Organovo Holdings Inc:

  • The MRQ is -40.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -36.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.6%TTM-36.9%-3.7%
TTM-36.9%YOY-10.1%-26.8%
TTM-36.9%5Y-17.8%-19.1%
5Y-17.8%10Y-16.1%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.6%-12.5%-28.1%
TTM-36.9%-12.2%-24.7%
YOY-10.1%-11.2%+1.1%
5Y-17.8%-13.4%-4.4%
10Y-16.1%-14.7%-1.4%
1.1.3. Return on Equity

Shows how efficient Organovo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Organovo to the Biotechnology industry mean.
  • -58.3% Return on Equity means Organovo generated $-0.58 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Organovo Holdings Inc:

  • The MRQ is -58.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -50.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-58.3%TTM-50.0%-8.3%
TTM-50.0%YOY-11.3%-38.7%
TTM-50.0%5Y-21.3%-28.6%
5Y-21.3%10Y-18.5%-2.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-58.3%-15.8%-42.5%
TTM-50.0%-15.7%-34.3%
YOY-11.3%-13.9%+2.6%
5Y-21.3%-18.3%-3.0%
10Y-18.5%-19.2%+0.7%

1.2. Operating Efficiency of Organovo Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Organovo is operating .

  • Measures how much profit Organovo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Organovo to the Biotechnology industry mean.
  • An Operating Margin of -75,040.0% means the company generated $-750.40  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Organovo Holdings Inc:

  • The MRQ is -75,040.0%. The company is operating very inefficient. -2
  • The TTM is -21,160.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-75,040.0%TTM-21,160.9%-53,879.1%
TTM-21,160.9%YOY-1,761.9%-19,399.1%
TTM-21,160.9%5Y-4,472,504,811.1%+4,472,483,650.2%
5Y-4,472,504,811.1%10Y-2,236,253,869.7%-2,236,250,941.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75,040.0%-299.1%-74,740.9%
TTM-21,160.9%-210.1%-20,950.8%
YOY-1,761.9%-279.7%-1,482.2%
5Y-4,472,504,811.1%-459.9%-4,472,504,351.2%
10Y-2,236,253,869.7%-596.9%-2,236,253,272.8%
1.2.2. Operating Ratio

Measures how efficient Organovo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 751.40 means that the operating costs are $751.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Organovo Holdings Inc:

  • The MRQ is 751.400. The company is inefficient in keeping operating costs low. -1
  • The TTM is 212.450. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ751.400TTM212.450+538.950
TTM212.450YOY18.795+193.655
TTM212.4505Y44,815,048.620-44,814,836.169
5Y44,815,048.62010Y22,407,551.681+22,407,496.938
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ751.4002.861+748.539
TTM212.4503.193+209.257
YOY18.7953.615+15.180
5Y44,815,048.6205.560+44,815,043.060
10Y22,407,551.6817.396+22,407,544.285

1.3. Liquidity of Organovo Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Organovo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.67 means the company has $3.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Organovo Holdings Inc:

  • The MRQ is 3.671. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.536. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.671TTM4.536-0.865
TTM4.536YOY18.897-14.361
TTM4.5365Y18.281-13.745
5Y18.28110Y16.259+2.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6713.986-0.315
TTM4.5364.440+0.096
YOY18.8975.552+13.345
5Y18.2816.158+12.123
10Y16.2596.492+9.767
1.3.2. Quick Ratio

Measures if Organovo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Organovo to the Biotechnology industry mean.
  • A Quick Ratio of 3.13 means the company can pay off $3.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Organovo Holdings Inc:

  • The MRQ is 3.134. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.189. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.134TTM3.189-0.055
TTM3.189YOY22.441-19.252
TTM3.1895Y18.227-15.037
5Y18.22710Y16.065+2.162
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1343.638-0.504
TTM3.1894.168-0.979
YOY22.4415.515+16.926
5Y18.2276.012+12.215
10Y16.0656.209+9.856

1.4. Solvency of Organovo Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Organovo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Organovo to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.30 means that Organovo assets are financed with 30.4% credit (debt) and the remaining percentage (100% - 30.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Organovo Holdings Inc:

  • The MRQ is 0.304. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.259. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.304TTM0.259+0.045
TTM0.259YOY0.101+0.159
TTM0.2595Y0.117+0.143
5Y0.11710Y0.097+0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3040.335-0.031
TTM0.2590.330-0.071
YOY0.1010.267-0.166
5Y0.1170.367-0.250
10Y0.0970.378-0.281
1.4.2. Debt to Equity Ratio

Measures if Organovo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Organovo to the Biotechnology industry mean.
  • A Debt to Equity ratio of 43.7% means that company has $0.44 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Organovo Holdings Inc:

  • The MRQ is 0.437. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.352. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.437TTM0.352+0.085
TTM0.352YOY0.112+0.240
TTM0.3525Y0.143+0.209
5Y0.14310Y0.114+0.029
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4370.376+0.061
TTM0.3520.398-0.046
YOY0.1120.334-0.222
5Y0.1430.429-0.286
10Y0.1140.476-0.362

2. Market Valuation of Organovo Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Organovo generates.

  • Above 15 is considered overpriced but always compare Organovo to the Biotechnology industry mean.
  • A PE ratio of -0.77 means the investor is paying $-0.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Organovo Holdings Inc:

  • The EOD is -0.703. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.773. Based on the earnings, the company is expensive. -2
  • The TTM is -0.994. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.703MRQ-0.773+0.070
MRQ-0.773TTM-0.994+0.221
TTM-0.994YOY-2.239+1.244
TTM-0.9945Y-2.768+1.774
5Y-2.76810Y-1.853-0.916
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.703-2.643+1.940
MRQ-0.773-2.418+1.645
TTM-0.994-2.742+1.748
YOY-2.239-4.123+1.884
5Y-2.768-6.257+3.489
10Y-1.853-6.478+4.625
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Organovo Holdings Inc:

  • The EOD is -0.720. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.791. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.942. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.720MRQ-0.791+0.071
MRQ-0.791TTM-0.942+0.151
TTM-0.942YOY-2.764+1.822
TTM-0.9425Y-3.707+2.765
5Y-3.70710Y-2.593-1.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.720-3.244+2.524
MRQ-0.791-2.939+2.148
TTM-0.942-3.478+2.536
YOY-2.764-5.592+2.828
5Y-3.707-8.473+4.766
10Y-2.593-8.881+6.288
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Organovo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.80 means the investor is paying $1.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Organovo Holdings Inc:

  • The EOD is 1.640. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.803. Based on the equity, the company is underpriced. +1
  • The TTM is 1.457. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.640MRQ1.803-0.162
MRQ1.803TTM1.457+0.346
TTM1.457YOY0.838+0.619
TTM1.4575Y1.413+0.044
5Y1.41310Y1.035+0.378
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6402.124-0.484
MRQ1.8032.041-0.238
TTM1.4572.118-0.661
YOY0.8382.915-2.077
5Y1.4133.682-2.269
10Y1.0354.114-3.079
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Organovo Holdings Inc.

3.1. Institutions holding Organovo Holdings Inc

Institutions are holding 8.232% of the shares of Organovo Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc2.84410279824-3401-1.2008
2023-09-30BlackRock Inc1.497801473611020.0693
2023-12-31Renaissance Technologies Corp1.03150.0002101487-7700-7.0521
2023-09-30Geode Capital Management, LLC0.7537074155951414.7182
2023-09-30Morgan Stanley - Brokerage Accounts0.3955038917-16255-29.4624
2023-09-30State Street Corporation0.282902783100
2023-09-30Northern Trust Corp0.149101467200
2023-09-30Susquehanna International Group, LLP0.1087010695-30611-74.1079
2023-09-30Tower Research Capital LLC0.05620.00025534-1121-16.8445
2023-09-30Advisor Group Holdings, Inc.0.02820277744519.0823
2023-09-30Albion Financial Group (Utah)0.01940.0002191200
2023-09-30Wells Fargo & Co0.00930912501121.8978
2023-09-30Quintet Private Bank (Europe) SA0.0051050020.4016
2023-09-30Bank of America Corp0.004038912547.3485
2023-09-30UBS Group AG0.0031030300
2023-09-30Goss Wealth Management LLC0.0010100-100-50
2023-09-30Crédit Agricole S.A.0.001010000
2023-09-30CWM, LLC duplicate0.000808000
2023-09-30The Toronto-Dominion Bank0.0008076760
2023-09-30JPMorgan Chase & Co0.00050501025
Total 7.19270.0006707675-48413-6.8%

3.2. Funds holding Organovo Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.3802023897200
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.14180.000111464000
2024-01-31Fidelity Extended Market Index0.44970.00014514700
2023-09-30BlackRock Extended Mkt Composite0.16660.00011672200
2023-12-31BlackRock Extended Equity Market K0.14530.000114589-29-0.1984
2024-01-31Fidelity Total Market Index0.118501189500
2024-01-31Fidelity Series Total Market Index0.095109550327352.1427
2024-01-31Fidelity Nasdaq Composite Index0.06920.0001694600
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06480.0001650100
2023-12-31Northern Trust Extended Eq Market Idx0.05990.0001601600
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05990.0001601600
2024-02-29iShares Core S&P Total US Stock Mkt ETF0.05330534800
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0520.00015221100.1919
2024-02-29State St US Extended Mkt Indx NL Cl C0.02950.0002296500
2023-12-31SSgA U.S. Extended Market Index Class I0.02950.0001296500
2024-01-31Spartan Extended Market Index Pool E0.02290.0001230000
2023-12-31Extended Equity Market Fund M0.0180.00011804865.0058
2024-01-31Spartan Total Market Index Pool E0.01530153500
2023-12-31Northern Trust Wilshire 50000.0089089100
2023-12-31NT US Market Cap Idx Fd - L0.0089089100
Total 4.98930.0014500914+3340+0.7%

3.3. Insider Transactions

Insiders are holding 3.053% of the shares of Organovo Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-15David GobelSELL196071.62

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Organovo Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.226-0.401+77%-0.224-1%-0.147-35%-0.106-53%
Book Value Per Share--0.6161.128-45%2.618-76%2.575-76%4.012-85%
Current Ratio--3.6714.536-19%18.897-81%18.281-80%16.259-77%
Debt To Asset Ratio--0.3040.259+17%0.101+202%0.117+161%0.097+213%
Debt To Equity Ratio--0.4370.352+24%0.112+290%0.143+205%0.114+284%
Dividend Per Share----0%-0%-0%-0%
Eps---0.359-0.390+9%-0.292-19%-0.396+10%-0.720+101%
Free Cash Flow Per Share---0.351-0.411+17%-0.237-33%-0.334-5%-0.498+42%
Free Cash Flow To Equity Per Share---0.234-0.381+63%-0.237+1%-0.152-35%-0.004-98%
Gross Profit Margin--1.0040.999+1%1.0070%1.001+0%1.003+0%
Intrinsic Value_10Y_max---9.553--------
Intrinsic Value_10Y_min---23.056--------
Intrinsic Value_1Y_max---1.148--------
Intrinsic Value_1Y_min---2.061--------
Intrinsic Value_3Y_max---3.303--------
Intrinsic Value_3Y_min---6.444--------
Intrinsic Value_5Y_max---5.284--------
Intrinsic Value_5Y_min---11.072--------
Market Cap10140501.000-10%11144511.00015662556.000-29%22565124.750-51%34136992.607-67%34404511.071-68%
Net Profit Margin---720.800-202.507-72%-16.814-98%-44750045.672+6208286%-22375037.314+3104095%
Operating Margin---750.400-211.609-72%-17.619-98%-44725048.111+5960061%-22362538.697+2979982%
Operating Ratio--751.400212.450+254%18.795+3898%44815048.620-100%22407551.681-100%
Pb Ratio1.640-10%1.8031.457+24%0.838+115%1.413+28%1.035+74%
Pe Ratio-0.703+9%-0.773-0.994+29%-2.239+190%-2.768+258%-1.853+140%
Price Per Share1.010-10%1.1101.560-29%2.248-51%3.400-67%3.427-68%
Price To Free Cash Flow Ratio-0.720+9%-0.791-0.942+19%-2.764+249%-3.707+369%-2.593+228%
Price To Total Gains Ratio-4.459+9%-4.901-3.295-33%-13.691+179%-1.235-75%-5.162+5%
Quick Ratio--3.1343.189-2%22.441-86%18.227-83%16.065-80%
Return On Assets---0.406-0.369-9%-0.101-75%-0.178-56%-0.161-60%
Return On Equity---0.583-0.500-14%-0.113-81%-0.213-63%-0.185-68%
Total Gains Per Share---0.226-0.401+77%-0.224-1%-0.147-35%-0.106-53%
Usd Book Value--6182000.00011324000.000-45%26289500.000-76%25854950.000-76%40283400.000-85%
Usd Book Value Change Per Share---0.226-0.401+77%-0.224-1%-0.147-35%-0.106-53%
Usd Book Value Per Share--0.6161.128-45%2.618-76%2.575-76%4.012-85%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.359-0.390+9%-0.292-19%-0.396+10%-0.720+101%
Usd Free Cash Flow---3522000.000-4122000.000+17%-2375750.000-33%-3349400.000-5%-5004000.000+42%
Usd Free Cash Flow Per Share---0.351-0.411+17%-0.237-33%-0.334-5%-0.498+42%
Usd Free Cash Flow To Equity Per Share---0.234-0.381+63%-0.237+1%-0.152-35%-0.004-98%
Usd Market Cap10140501.000-10%11144511.00015662556.000-29%22565124.750-51%34136992.607-67%34404511.071-68%
Usd Price Per Share1.010-10%1.1101.560-29%2.248-51%3.400-67%3.427-68%
Usd Profit---3604000.000-5513250.000+53%-2877750.000-20%-4281000.000+19%-6341525.000+76%
Usd Revenue--5000.00082250.000-94%427000.000-99%245650.001-98%458150.000-99%
Usd Total Gains Per Share---0.226-0.401+77%-0.224-1%-0.147-35%-0.106-53%
 EOD+3 -5MRQTTM+14 -20YOY+4 -305Y+8 -2610Y+12 -22

4.2. Fundamental Score

Let's check the fundamental score of Organovo Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.703
Price to Book Ratio (EOD)Between0-11.640
Net Profit Margin (MRQ)Greater than0-720.800
Operating Margin (MRQ)Greater than0-750.400
Quick Ratio (MRQ)Greater than13.134
Current Ratio (MRQ)Greater than13.671
Debt to Asset Ratio (MRQ)Less than10.304
Debt to Equity Ratio (MRQ)Less than10.437
Return on Equity (MRQ)Greater than0.15-0.583
Return on Assets (MRQ)Greater than0.05-0.406
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Organovo Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.956
Ma 20Greater thanMa 501.028
Ma 50Greater thanMa 1001.023
Ma 100Greater thanMa 2001.128
OpenGreater thanClose1.050
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets8,881
Total Liabilities2,699
Total Stockholder Equity6,182
 As reported
Total Liabilities 2,699
Total Stockholder Equity+ 6,182
Total Assets = 8,881

Assets

Total Assets8,881
Total Current Assets6,241
Long-term Assets2,640
Total Current Assets
Cash And Cash Equivalents 5,295
Net Receivables 33
Other Current Assets 913
Total Current Assets  (as reported)6,241
Total Current Assets  (calculated)6,241
+/-0
Long-term Assets
Property Plant Equipment 2,142
Long-term Assets Other 355
Long-term Assets  (as reported)2,640
Long-term Assets  (calculated)2,497
+/- 143

Liabilities & Shareholders' Equity

Total Current Liabilities1,700
Long-term Liabilities999
Total Stockholder Equity6,182
Total Current Liabilities
Short-term Debt 502
Accounts payable 471
Other Current Liabilities 727
Total Current Liabilities  (as reported)1,700
Total Current Liabilities  (calculated)1,700
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt999
Long-term Liabilities  (as reported)999
Long-term Liabilities  (calculated)999
+/- 0
Total Stockholder Equity
Common Stock10
Retained Earnings -336,624
Accumulated Other Comprehensive Income 1
Other Stockholders Equity 342,795
Total Stockholder Equity (as reported)6,182
Total Stockholder Equity (calculated)6,182
+/-0
Other
Capital Stock10
Cash and Short Term Investments 5,295
Common Stock Shares Outstanding 9,115
Liabilities and Stockholders Equity 8,881
Net Debt -3,794
Net Invested Capital 6,182
Net Working Capital 4,541
Property Plant and Equipment Gross 2,142
Short Long Term Debt Total 1,501



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-03-31
> Total Assets 
0
0
0
63
4
4
3
11,241
9,709
9,043
16,749
17,375
14,508
54,898
51,615
50,186
46,908
56,542
52,070
53,489
90,563
81,676
74,536
67,576
58,847
57,536
76,131
69,180
61,712
56,911
53,554
49,827
45,092
42,625
39,685
40,623
43,451
37,771
31,312
28,441
25,621
20,644
21,581
39,917
38,294
35,881
35,095
33,296
30,546
27,910
25,079
20,313
20,313
11,161
8,881
8,88111,16120,31320,31325,07927,91030,54633,29635,09535,88138,29439,91721,58120,64425,62128,44131,31237,77143,45140,62339,68542,62545,09249,82753,55456,91161,71269,18076,13157,53658,84767,57674,53681,67690,56353,48952,07056,54246,90850,18651,61554,89814,50817,37516,7499,0439,70911,24134463000
   > Total Current Assets 
0
0
0
34
4
4
3
10,835
9,201
8,228
15,866
16,144
13,261
53,735
50,529
49,161
45,740
55,105
50,468
51,262
86,996
77,825
70,745
63,652
55,181
53,682
71,943
65,092
57,868
53,344
50,268
46,760
42,312
40,117
37,471
38,574
37,356
32,714
31,106
28,318
25,501
19,485
20,099
38,398
36,658
34,303
31,171
29,533
26,909
24,357
21,614
17,048
17,048
8,296
6,241
6,2418,29617,04817,04821,61424,35726,90929,53331,17134,30336,65838,39820,09919,48525,50128,31831,10632,71437,35638,57437,47140,11742,31246,76050,26853,34457,86865,09271,94353,68255,18163,65270,74577,82586,99651,26250,46855,10545,74049,16150,52953,73513,26116,14415,8668,2289,20110,83534434000
       Cash And Cash Equivalents 
0
0
0
32
2
2
1
10,353
8,469
7,676
14,817
15,628
12,849
53,357
49,818
48,167
44,897
54,389
50,027
50,142
86,000
76,863
70,026
62,091
53,538
51,723
69,996
62,751
54,974
50,732
47,338
43,726
39,613
37,355
35,224
36,477
35,487
30,350
30,467
27,356
24,787
17,656
18,836
37,364
36,008
33,791
30,269
28,675
15,568
13,265
20,196
15,301
15,301
7,617
5,295
5,2957,61715,30115,30120,19613,26515,56828,67530,26933,79136,00837,36418,83617,65624,78727,35630,46730,35035,48736,47735,22437,35539,61343,72647,33850,73254,97462,75169,99651,72353,53862,09170,02676,86386,00050,14250,02754,38944,89748,16749,81853,35712,84915,62814,8177,6768,46910,35312232000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,624
10,573
554
706
706
0
0
0070670655410,57310,624000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
95
162
101
0
0
7
40
60
30
0
0
132
180
165
259
103
606
1,030
647
772
1,182
1,434
1,028
728
928
671
558
637
619
165
111
84
19
0
0
0
0
0
0
0
0
76
152
152
55
33
3355152152760000000019841111656196375586719287281,0281,4341,1827726471,0306061032591651801320030604070010116295000000000
       Other Current Assets 
0
0
0
3
3
3
3
145
204
145
527
327
327
304
622
891
712
616
372
1,054
795
714
483
968
1,028
908
589
1,144
1,661
934
891
1,164
927
798
527
1,049
726
1,394
474
851
630
1,810
1,263
1,034
650
512
902
858
717
519
788
889
889
624
913
9136248898897885197178589025126501,0341,2631,8106308514741,3947261,0495277989271,1648919341,6611,1445899081,0289684837147951,0543726167128916223043273275271452041453333000
   > Long-term Assets 
0
0
0
28
0
0
0
406
508
815
883
1,231
1,247
1,163
1,086
1,025
1,168
1,437
1,602
2,227
3,567
3,851
3,791
3,924
3,666
3,854
4,188
4,088
3,844
3,567
3,286
3,067
2,780
2,508
2,214
2,049
6,095
5,057
206
123
120
1,159
1,482
1,519
1,636
1,578
3,924
3,763
3,637
3,553
3,465
3,265
3,265
2,865
2,640
2,6402,8653,2653,2653,4653,5533,6373,7633,9241,5781,6361,5191,4821,1591201232065,0576,0952,0492,2142,5082,7803,0673,2863,5673,8444,0884,1883,8543,6663,9243,7913,8513,5672,2271,6021,4371,1681,0251,0861,1631,2471,23188381550840600028000
       Property Plant Equipment 
0
0
0
0
0
0
0
269
323
606
714
1,045
1,113
1,031
915
857
1,001
1,273
1,440
2,042
3,381
3,633
3,560
3,711
3,456
3,647
3,937
3,840
3,528
3,255
2,978
2,788
2,504
2,236
1,946
1,832
5,882
4,847
0
0
0
22
289
381
554
552
2,921
2,815
2,746
2,716
2,545
2,607
2,607
2,313
2,142
2,1422,3132,6072,6072,5452,7162,7462,8152,921552554381289220004,8475,8821,8321,9462,2362,5042,7882,9783,2553,5283,8403,9373,6473,4563,7113,5603,6333,3812,0421,4401,2731,0018579151,0311,1131,0457146063232690000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79
0
79
79
79
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000079797907900000000000000
       Intangible Assets 
0
0
0
28
0
0
0
0
0
0
80
0
0
0
0
89
0
0
0
80
0
0
0
105
0
0
0
95
0
0
0
151
0
0
0
137
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
0
0
0013000000000000000013700015100095000105000800008900008000000028000
       Other Assets 
0
0
0
0
0
3
3
137
185
209
169
186
134
132
171
168
167
164
162
185
186
218
231
213
210
207
251
248
316
312
308
128
276
272
268
217
213
210
206
123
120
1,137
2,456
1,029
1,082
1,026
1,003
854
891
837
920
645
605
0
0
006056459208378918541,0031,0261,0821,0292,4561,1371201232062102132172682722761283083123162482512072102132312181861851621641671681711321341861692091851373300000
> Total Liabilities 
0
0
0
1
11
11
74
48,626
81,467
36,467
22,052
8,406
7,600
2,956
2,914
1,902
3,090
3,114
3,760
4,793
5,244
5,525
5,497
5,395
4,004
5,049
5,227
6,818
4,443
4,853
4,953
5,241
3,736
3,755
4,010
4,325
7,312
6,698
2,358
1,810
835
657
829
721
964
1,675
3,802
3,087
2,892
2,904
2,790
4,984
4,984
2,705
2,699
2,6992,7054,9844,9842,7902,9042,8923,0873,8021,6759647218296578351,8102,3586,6987,3124,3254,0103,7553,7365,2414,9534,8534,4436,8185,2275,0494,0045,3955,4975,5255,2444,7933,7603,1143,0901,9022,9142,9567,6008,40622,05236,46781,46748,6267411111000
   > Total Current Liabilities 
0
0
0
1
11
11
74
1,111
889
976
22,035
8,382
7,580
2,940
2,901
1,893
3,085
3,112
3,716
4,761
5,225
5,518
5,497
4,490
3,136
4,220
4,441
6,011
3,688
4,125
4,297
4,658
3,210
3,291
3,410
3,737
3,538
3,122
2,358
1,810
835
658
829
721
964
1,675
2,006
1,383
1,282
1,389
1,376
3,671
3,671
1,600
1,700
1,7001,6003,6713,6711,3761,3891,2821,3832,0061,6759647218296588351,8102,3583,1223,5383,7373,4103,2913,2104,6584,2974,1253,6886,0114,4414,2203,1364,4905,4975,5185,2254,7613,7163,1123,0851,8932,9012,9407,5808,38222,0359768891,1117411111000
       Short-term Debt 
0
0
0
0
0
0
10
0
0
10
10
10
10
10
10
10
11
10
8
5
2
3,533
3,573
2,589
1,855
2,978
3,091
0
0
0
0
0
0
0
0
0
1,046
1,038
0
0
0
0
0
0
0
0
475
479
482
486
488
0
492
499
502
5024994920488486482479475000000001,0381,0460000000003,0912,9781,8552,5893,5733,5332581011101010101010100010000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15
0
0
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000500015000000000000000
       Accounts payable 
0
0
0
1
11
11
61
441
260
61
425
641
374
477
311
326
839
530
495
1,387
1,030
567
466
787
481
754
722
1,171
558
477
452
464
396
449
647
628
553
152
822
720
110
201
411
281
577
958
605
415
130
441
242
331
331
435
471
4714353313312424411304156059585772814112011107208221525536286474493964644524775581,1717227544817874665671,0301,387495530839326311477374641425612604416111111000
       Other Current Liabilities 
0
0
0
0
0
3
0
401
406
830
20,619
7,678
7,168
2,378
2,565
1,544
2,091
2,432
2,972
3,142
2,760
16
14
4
9
9
8
4,258
2,276
2,994
2,988
3,526
2,186
2,223
2,183
2,584
1,407
1,932
1,536
1,090
725
457
418
440
387
717
926
489
670
462
646
0
2,848
666
727
7276662,84806464626704899267173874404184577251,0901,5361,9321,4072,5842,1832,2232,1863,5262,9882,9942,2764,258899414162,7603,1422,9722,4322,0911,5442,5652,3787,1687,67820,6198304064010300000
   > Long-term Liabilities 
0
0
0
1
0
11
74
47,515
80,578
35,491
17
24
20
16
13
9
5
2
44
32
19
7
1,910
905
868
829
786
807
755
728
656
583
526
464
600
588
3,774
3,576
822
720
110
-1
411
281
577
958
1,796
1,704
1,610
1,515
1,414
1,313
1,313
1,105
999
9991,1051,3131,3131,4141,5151,6101,7041,796958577281411-11107208223,5763,7745886004645265836567287558077868298689051,9107193244259131620241735,49180,57847,515741101000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
0
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000120800000000000000
       Other Liabilities 
0
0
0
0
0
0
0
47,515
80,578
35,471
0
9
8
6
5
4
3
1
44
32
19
7
0
905
868
829
786
807
755
728
656
583
526
464
600
588
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000588600464526583656728755807786829868905071932441345689035,47180,57847,5150000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
3
1
44
32
19
7
0
905
868
829
786
807
755
728
656
583
516
464
600
588
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000058860046451658365672875580778682986890507193244130500000000000000
> Total Stockholder Equity
0
0
0
62
-6
-6
-71
-37,385
-71,758
-27,424
-5,303
8,969
6,908
51,942
48,701
48,284
43,818
53,428
48,310
48,696
85,319
76,151
69,039
62,181
54,843
52,487
70,904
62,362
57,269
52,058
48,601
44,586
41,356
38,870
35,675
36,298
36,139
31,073
28,954
26,631
24,786
19,987
20,752
39,196
37,330
34,206
31,293
30,209
27,654
25,006
22,289
15,329
15,329
8,456
6,182
6,1828,45615,32915,32922,28925,00627,65430,20931,29334,20637,33039,19620,75219,98724,78626,63128,95431,07336,13936,29835,67538,87041,35644,58648,60152,05857,26962,36270,90452,48754,84362,18169,03976,15185,31948,69648,31053,42843,81848,28448,70151,9426,9088,969-5,303-27,424-71,758-37,385-71-6-662000
   Common Stock
0
0
0
1
1
1
1
44
44
47
59
65
65
77
77
78
78
80
80
82
92
92
92
92
92
94
104
104
106
107
109
111
113
115
118
124
130
130
130
131
131
7
7
9
9
9
9
9
9
9
9
0
9
9
10
109909999999977131131130130130124118115113111109107106104104949292929292828080787877776565594744441111000
   Retained Earnings Total Equity0000000000-298,8230-293,695-291,184-282,234-279,465-276,742-273,372-267,078-260,755-253,772-247,373-241,536-234,120-226,671-218,880-209,419-199,317-188,660-179,079-169,637-160,870-152,498-142,043-130,7860-114,497-107,504-98,6460-85,73100000000-20900000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-192
-270
0
0
0
-574
-574
0
0
-1,002
-1,002
0
0
-1,806
-1,806
-7
-10
-11
-11
-11
-13
-4,068
0
0
0
-4,581
-4,581
0
0
-415
0
0
0
-1,002
-1,002
0
0
0
0
0
3
0
2
1
1
1120300000-1,002-1,002000-41500-4,581-4,581000-4,068-13-11-11-11-10-7-1,806-1,80600-1,002-1,00200-574-574000-270-1920000000000
   Capital Surplus 
0
0
0
0
0
180
0
0
0
0
0
0
0
0
134,355
0
142,386
160,852
162,727
0
216,013
218,102
221,445
222,959
224,388
231,479
259,470
261,586
266,593
270,842
275,176
278,595
282,779
286,128
289,329
296,929
303,087
304,315
305,566
305,965
306,889
311,164
314,441
0
336,145
0
0
0
0
0
0
0
0
0
0
0000000000336,1450314,441311,164306,889305,965305,566304,315303,087296,929289,329286,128282,779278,595275,176270,842266,593261,586259,470231,479224,388222,959221,445218,102216,0130162,727160,852142,3860134,3550000000018000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
177
179
179
181
6,343
7,356
13,208
44,883
75,269
76,979
132,387
134,355
140,419
142,386
160,852
162,727
171,911
216,013
218,102
221,445
224,765
224,388
231,479
259,470
261,586
266,593
270,842
275,176
282,663
282,779
286,128
289,329
301,510
303,087
304,315
305,566
306,380
306,889
311,164
314,440
336,480
336,144
336,525
337,112
337,939
338,599
339,272
339,816
2
340,316
341,466
342,795
342,795341,466340,3162339,816339,272338,599337,939337,112336,525336,144336,480314,440311,164306,889306,380305,566304,315303,087301,510289,329286,128282,779282,663275,176270,842266,593261,586259,470231,479224,388224,765221,445218,102216,013171,911162,727160,852142,386140,419134,355132,38776,97975,26944,88313,2087,3566,343181179179177000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue370
Cost of Revenue-293
Gross Profit7777
 
Operating Income (+$)
Gross Profit77
Operating Expense-18,101
Operating Income-17,731-18,024
 
Operating Expense (+$)
Research Development8,885
Selling General Administrative9,088
Selling And Marketing Expenses0
Operating Expense18,10117,973
 
Net Interest Income (+$)
Interest Income454
Interest Expense--470
Other Finance Cost-470
Net Interest Income454
 
Pretax Income (+$)
Operating Income-17,731
Net Interest Income454
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,257-18,205
EBIT - interestExpense = -17,261
-17,257
-17,729
Interest Expense-470
Earnings Before Interest and Taxes (EBIT)-17,731-17,727
Earnings Before Interest and Taxes (EBITDA)-17,458
 
After tax Income (+$)
Income Before Tax-17,257
Tax Provision-2
Net Income From Continuing Ops-17,259-17,259
Net Income-17,259
Net Income Applicable To Common Shares-17,259
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses18,101
Total Other Income/Expenses Net474-454
 

Technical Analysis of Organovo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Organovo. The general trend of Organovo is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Organovo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Organovo Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.17 < 1.24 < 1.27.

The bearish price targets are: 0.99 > 0.96 > 0.8911.

Tweet this
Organovo Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Organovo Holdings Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Organovo Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Organovo Holdings Inc. The current macd is 0.00134946.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Organovo price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Organovo. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Organovo price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Organovo Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartOrganovo Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Organovo Holdings Inc. The current adx is 29.60.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Organovo shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Organovo Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Organovo Holdings Inc. The current sar is 1.20277547.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Organovo Holdings Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Organovo Holdings Inc. The current rsi is 46.96. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Organovo Holdings Inc Daily Relative Strength Index (RSI) ChartOrganovo Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Organovo Holdings Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Organovo price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Organovo Holdings Inc Daily Stochastic Oscillator ChartOrganovo Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Organovo Holdings Inc. The current cci is -16.87732157.

Organovo Holdings Inc Daily Commodity Channel Index (CCI) ChartOrganovo Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Organovo Holdings Inc. The current cmo is -10.15458081.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Organovo Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartOrganovo Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Organovo Holdings Inc. The current willr is -92.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Organovo Holdings Inc Daily Williams %R ChartOrganovo Holdings Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Organovo Holdings Inc.

Organovo Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Organovo Holdings Inc. The current atr is 0.07218567.

Organovo Holdings Inc Daily Average True Range (ATR) ChartOrganovo Holdings Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Organovo Holdings Inc. The current obv is 17,217,216.

Organovo Holdings Inc Daily On-Balance Volume (OBV) ChartOrganovo Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Organovo Holdings Inc. The current mfi is 77.51.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Organovo Holdings Inc Daily Money Flow Index (MFI) ChartOrganovo Holdings Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Organovo Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Organovo Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Organovo Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.956
Ma 20Greater thanMa 501.028
Ma 50Greater thanMa 1001.023
Ma 100Greater thanMa 2001.128
OpenGreater thanClose1.050
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Organovo with someone you think should read this too:
  • Are you bullish or bearish on Organovo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Organovo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Organovo Holdings Inc

I send you an email if I find something interesting about Organovo Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Organovo Holdings Inc.

Receive notifications about Organovo Holdings Inc in your mailbox!